English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Bladder cancer is a highly prevalent disease and is associated with substantial morbidity, mortality if not treated optimally. We aimed to describe bladder cancer incidence and trends from 2002 to 2013 and to estimate predictions up to 2030. Methods We performed an observational study from 2002 to 2013. Incidence was estimated by the crude incidence rate (CIR) and standardized incidence rate (SIR). Poisson regression model was used to calculate the slope 'b' in order to describe trends and was performed to estimate incidence projection for 2030. Data were verified and analyzed using IBM SPSS Statistics version 22.0 software. Results A total of 1024 cases of bladder cancer was declared from 2002 to 2013 predominately among males with a rate of 90.4%. CIR was 16.79/100,000 inhabitants (inh) and SIR was 21.38/100,000 inh. By gender, SIR was 41.3/100,000 inh and 7.73/100,000 inh for males and females respectively. During our study period a significant positive trend was noted with a (b = 0.042, p &amp;lt; 10-4). In 2030, the predicted incidence rate would increase to 28.4/100,000 inh. Conclusions The findings have highlighted the positive trend and the increased predicted incidence of bladder cancer in 2030. Thus, developing primary prevention strategies is crucial. Key messages Our results are important for health-care professionals to improve planning policies related to bladder cancer. Identifying associated factors is crucial to guide preventive strategies measures.

Bladder cancer incidence and predictions: Observational Study (Monastir, Tunisia: (2002-2030)